Introduction to Artificial Neural Network (ANN) as a Predictive Tool for Drug Design, Discovery, Delivery, and Disposition: Basic Concepts and Modeling. Basic Concepts and Modeling

Artificial Neural Network for Drug Design, Delivery and Disposition

Volumn , Issue , 2016, Pages 3-13

  Puri, Munish ^a,b,c   Solanki, Aum ^d   Padawer, Timothy ^d   Tipparaju, Srinivas M ^d   Moreno, Wilfrido Alejandro ^e,f   Pathak, Yashwant ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e University of South Florida   (United States)

^f R and D of Ibero American Sci and Tech Edu Consort (ISTEC)   (United States)

Author keywords

ANN as classifier; ANN in Blood Brain Barrier (BBB) permeability; ANN in medicine; Artificial Neural Network; Neural network in pharmaceutical

Indexed keywords

BACKPROPAGATION; BLOOD; CONTROLLED DRUG DELIVERY; NEURONS; REINFORCEMENT LEARNING; TARGETED DRUG DELIVERY;

BIOLOGICAL NEURON; BLOOD-BRAIN BARRIER; COMPUTATIONAL MODEL; COMPUTATIONAL PROCESSING; PARALLEL PROCESSING; PHARMACEUTICAL RESEARCH; PREDICTIVE TOOLS; STRUCTURAL ARRANGEMENT;

NEURAL NETWORKS;

EID: 84967360252     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-801559-9.00001-6     Document Type: Chapter

References (29)

1. Masoudi-Nejad A., Mousavian Z., Bozorgmehr J.H. Drug-target and disease networks: polypharmacology in the post-genomic era. Silico Pharmacol 2013, 1:17.
2. Horter D., Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001, 46(1-3):75-87.
3. Sjogren E., et al. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Eur J Pharm Sci 2013, 49(4):679-698.
4. Takahashi M.B., et al. Artificial neural network associated to UV/Vis spectroscopy for monitoring bioreactions in biopharmaceutical processes. Bioprocess Biosyst Eng 2015, 1-10.
5. Kaliszan R., et al. Molecular mechanism of retention in reversed-phase high-performance liquid chromatography and classification of modern stationary phases by using quantitative structure-retention relationships. J Chromatogr A 1999, 855(2):455-486.
6. Tham S., Agatonovic-Kustrin S. Application of the artificial neural network in quantitative structure-gradient elution retention relationship of phenylthiocarbamyl amino acids derivatives. J Pharm Biomed Anal 2002, 28(3):581-590.
7. D'Archivio A.A., Maggi M.A., Ruggieri F. Cross-column prediction of gas-chromatographic retention indices of saturated esters. J Chromatogr A 2014.
8. z) in LC-MS metabolite profiling. Phytochemistry 2014, 108:196-207.
9. Ebube N.K., Owusu-Ababio G., Adeyeye C.M. Preformulation studies and characterization of the physicochemical properties of amorphous polymers using artificial neural networks. Int J Pharm 2000, 196(1):27-35.
10. Chen Y., et al. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. J Control Release 1999, 59(1):33-41.
11. Subramanian N., Yajnik A., Murthy R.S.R. Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes. AAPS PharmSciTech 2004, 5(1):11-19.
12. Kumar K., Panpalia G., Priyadarshini S. Application of artificial neural networks in optimizing the fatty alcohol concentration in the formulation of an O/W emulsion. Acta Pharm 2011, 61(2):249-256.
13. Aghajani M., Shahverdi A.R., Amani A. The use of artificial neural networks for optimizing polydispersity index (PDI) in nanoprecipitation process of acetaminophen in microfluidic devices. AAPS PharmSciTech 2012, 13(4):1293-1301.
14. Xie H., et al. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network. Drug Dev Ind Pharm 2008, 34(4):363-372.
15. Dowell J.A., et al. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. J Pharm Sci 1999, 88(1):154-160.
16. Parojčić J., et al. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. Eur J Pharm Sci 2007, 30(3):264-272.
17. De Matas M., et al. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks. Eur J Pharm Sci 2008, 33(1):80-90.
18. De Matas M., et al. Predicting the clinical effect of a short acting bronchodilator in individual patients using artificial neural networks. Eur J Pharm Sci 2010, 41(5):707-715.
19. Fatouros D.G., et al. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks. Eur J Pharm Biopharm 2008, 69(3):887-898.
20. Ilić M., et al. In vitro-in silico-in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: Nifedipine osmotic release tablets case study. Eur J Pharm Sci 2014, 62:212-218.
21. Paixão P., Gouveia L.F., Morais J.A. Prediction of the in vitro intrinsic clearance determined in suspensions of human hepatocytes by using artificial neural networks. Eur J Pharm Sci 2010, 39(5):310-321.
22. Mendyk A., et al. Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks. Drug Des Dev Ther 2013, 7:223.
23. Wilhelm I., Fazakas C., Krizbai I.A. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 2011, 71(1):113-128.
24. Garg P., Verma J. In silico prediction of blood-brain barrier permeability: an artificial neural network model. J Chem Inf Model 2006, 46(1):289-297.
25. Chen Y., et al. A prediction model for blood-brain barrier permeation and analysis on its parameter biologically. Comput Methods Programs Biomed 2009, 95(3):280-287.
26. Montañez-Godínez N., et al. QSAR/QSPR as an application of artificial neural networks. Artificial neural networks 2015, 319-333. Springer.
27. Kövesdi I., et al. Application of neural networks in structure-activity relationships. Med Res Rev 1999, 19(3):249-269.
28. Hadjmohammadi M., Fatemi M., Kamel K. Quantitative structure-property relationship study of retention time of some pesticides in gas chromatography. J Chromatogr Sci 2007, 45(7):400-404.
29. Vucicevic J., et al. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis. Eur J Pharm Sci 2015, 68:94-105.